Altrinsic Global Advisors LLC Biogen Inc. Transaction History

Altrinsic Global Advisors LLC

  • $2.15 Billion
  • Q3 2024

A detailed history of Altrinsic Global Advisors LLC transactions in Biogen Inc. stock. As of the latest transaction made, Altrinsic Global Advisors LLC holds 39,350 shares of BIIB stock, worth $6.14 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares
39,350
Previous 40,442 2.7%
Holding current value
$6.14 Million
Previous $9.38 Million 18.65%
% of portfolio
0.35%
Previous 0.45%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$189.07 - $236.8 $206,464 - $258,585
-1,092 Reduced 2.7%
39,350 $7.63 Million
Q2 2024

Aug 14, 2024
SELL
$190.52 - $236.72 $304,260 - $378,041
-1,597 Reduced 3.8%
40,442 $9.38 Million
Q1 2024

May 14, 2024
SELL
$212.02 - $267.71 $532,594 - $672,487
-2,512 Reduced 5.64%
42,039 $9.06 Million
Q4 2023

Feb 14, 2024
SELL
$222.59 - $267.94 $580,959 - $699,323
-2,610 Reduced 5.53%
44,551 $11.5 Million
Q3 2023

Nov 14, 2023
SELL
$253.3 - $285.89 $611,466 - $690,138
-2,414 Reduced 4.87%
47,161 $12.1 Million
Q2 2023

Aug 14, 2023
SELL
$275.25 - $318.06 $605,825 - $700,050
-2,201 Reduced 4.25%
49,575 $14.1 Million
Q1 2023

May 15, 2023
BUY
$256.56 - $292.34 $3.19 Million - $3.64 Million
12,449 Added 31.66%
51,776 $14.4 Million
Q4 2022

Feb 14, 2023
SELL
$252.44 - $306.72 $484,684 - $588,902
-1,920 Reduced 4.65%
39,327 $10.9 Million
Q3 2022

Nov 14, 2022
SELL
$194.69 - $268.46 $5.16 Million - $7.12 Million
-26,518 Reduced 39.13%
41,247 $11 Million
Q2 2022

Aug 15, 2022
SELL
$187.54 - $223.02 $760,099 - $903,900
-4,053 Reduced 5.64%
67,765 $13.8 Million
Q1 2022

May 16, 2022
SELL
$193.77 - $244.14 $7.8 Million - $9.83 Million
-40,265 Reduced 35.92%
71,818 $15.1 Million
Q4 2021

Feb 14, 2022
SELL
$223.92 - $287.77 $3.12 Million - $4.01 Million
-13,938 Reduced 11.06%
112,083 $26.9 Million
Q3 2021

Nov 15, 2021
BUY
$282.99 - $369.05 $330,532 - $431,050
1,168 Added 0.94%
126,021 $35.7 Million
Q2 2021

Aug 13, 2021
SELL
$259.0 - $414.71 $375,809 - $601,744
-1,451 Reduced 1.15%
124,853 $43.2 Million
Q1 2021

May 14, 2021
SELL
$242.95 - $284.63 $609,075 - $713,567
-2,507 Reduced 1.95%
126,304 $35.3 Million
Q4 2020

Feb 16, 2021
BUY
$236.26 - $355.63 $1.44 Million - $2.17 Million
6,102 Added 4.97%
128,811 $31.5 Million
Q3 2020

Nov 16, 2020
SELL
$264.77 - $305.71 $1.76 Million - $2.03 Million
-6,634 Reduced 5.13%
122,709 $34.8 Million
Q2 2020

Aug 14, 2020
BUY
$258.66 - $342.55 $1.52 Million - $2.02 Million
5,887 Added 4.77%
129,343 $34.6 Million
Q1 2020

May 14, 2020
SELL
$268.85 - $341.04 $3.36 Million - $4.26 Million
-12,488 Reduced 9.19%
123,456 $39.1 Million
Q4 2019

Feb 14, 2020
SELL
$220.06 - $304.07 $3.37 Million - $4.66 Million
-15,336 Reduced 10.14%
135,944 $40.3 Million
Q3 2019

Nov 14, 2019
BUY
$217.44 - $243.88 $3.26 Million - $3.66 Million
14,993 Added 11.0%
151,280 $35.2 Million
Q2 2019

Aug 14, 2019
BUY
$219.29 - $241.72 $6.18 Million - $6.82 Million
28,202 Added 26.09%
136,287 $31.9 Million
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $3.13 Million - $4.9 Million
14,458 Added 15.44%
108,085 $25.5 Million
Q4 2018

Feb 14, 2019
BUY
$278.5 - $352.75 $3.18 Million - $4.02 Million
11,410 Added 13.88%
93,627 $28.2 Million
Q3 2018

Nov 14, 2018
SELL
$293.51 - $383.83 $4.76 Million - $6.22 Million
-16,218 Reduced 16.48%
82,217 $29 Million
Q2 2018

Aug 13, 2018
BUY
$257.52 - $306.91 $8.32 Million - $9.91 Million
32,293 Added 48.82%
98,435 $28.6 Million
Q1 2018

May 14, 2018
SELL
$260.13 - $367.91 $6.76 Million - $9.56 Million
-25,979 Reduced 28.2%
66,142 $18.1 Million
Q4 2017

Feb 13, 2018
SELL
$307.64 - $344.58 $7.31 Million - $8.19 Million
-23,769 Reduced 20.51%
92,121 $29.3 Million
Q3 2017

Nov 14, 2017
BUY
$281.15 - $329.69 $32.6 Million - $38.2 Million
115,890
115,890 $36.3 Million

Others Institutions Holding BIIB

# of Institutions
1,036
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email